Shingrix was originally approved by the FDA in 2017 for the prevention of shingles in adults 50 years and older. Now, it’s approved for those 18 years and older who are immunocompromised.
Armand Butera
Advertisement
Articles by Armand Butera
Advertisement
Latest Updated Articles
Infection Prevention Connection: An IPC Crossword ChallengePublished: August 11th 2025 | Updated: August 13th 2025
Championing Surgical Safety: A Perioperative Nurse’s Perspective on Infection PreventionPublished: July 22nd 2025 | Updated: July 23rd 2025
Alcohol-Based Hand Sanitizers Ineffective Against Norovirus: Effective Alternatives and Infection Control StrategiesPublished: May 30th 2024 | Updated: January 7th 2025
Norovirus: An Old Virus Seeking New Public Health ActionsPublished: May 3rd 2024 | Updated: January 6th 2025
Meet Infection Control Today's Editorial Board Member: Tabrikah Mohammed, MSc, BSN, CIC, CPHQ, FAPICPublished: March 5th 2024 | Updated: August 6th 2024
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine ConfidencePublished: July 15th 2025 | Updated:
Advertisement
Advertisement
